Boardroom Alpha
Start trial
10-K primary document
LFCR · Annual Report (Form 10-K) · Filed August 7, 2025

Lifecore Biomedical Inc — 10-K exhibit

lfcr-20250525xexx1039josep.htm
Lifecore Biomedical Inc on Boardroom Alpha
Document
3515 Lyman Boulevard
Chaska, Minnesota
55318-3051 USA
image_0a.jpg

Exhibit 10.39


May 9, 2025

Paul Josephs
17 Grogan Mill

San Antonio, TX 78248

RE: Amendment to Offer Letter dated March 20, 2024 between Paul Josephs and Lifecore Biomedical, Inc. (the “Offer Letter”)

Dear Paul:

This letter sets forth an amendment (“Amendment”) to the Offer Letter that has been mutually agreed between, and duly authorized by, you and Lifecore. All capitalized terms used in this Amendment and not otherwise defined shall have the meanings set forth in the Offer Letter.

    The paragraph in the Offer Letter entitled “Relocation” is hereby amended and restated in its entirety as follows:

Relocation: Your position will be based in San Antonio, Texas. While you will not be required to maintain a residence in the same location as Lifecore’s headquarters, you will travel to Lifecore’s headquarters as appropriate to fulfill your job responsibilities.

For so long as you do not live in the vicinity of the Lifecore’s headquarters, Lifecore will reimburse you for reasonable out of pocket expenses, up to a maximum amount to be set by the compensation committee annually, associated with (1) monthly rent of an apartment, hotel accommodations or other similar temporary housing (including utilities); (2) rental car or a car allowance for travel in the Twin Cities; and (3) airfare for four trips per month from your current residence to the Twin Cities. Reimbursement is not provided for personal meal or entertainment expenses during your in-office time, unless those expenses are for business purposes. Initially, the maximum amount of reimbursement of these expenses will be $5,000 per month.

    Except for the paragraph specifically amended herein, all terms and conditions of the Offer Letter shall remain in full force and effect. This Amendment shall hereafter be incorporated into and deemed part of the Offer Letter and any future reference to the Offer Letter shall include the terms and conditions of this Amendment.



The parties have duly executed this Amendment as of the date first set forth above.


Lifecore Biomedical, Inc.


By: /s/ Thomas D. Salus
Thomas D. Salus
Chief Legal & Administration Officer


ACCEPTED AND AGREED:


/s/ Paul Josephs
Paul Josephs

















2



[Signature Page to Amendment to Paul Josephs Offer Letter]
3

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer